Valproate and the risk of fracture in Rett syndrome
MetadataShow full item record
Objectives - Some associations between antiepileptic drugs (AEDs) and fracture risk have been reported in the general population. This study investigated the relationships between fracture risk and commonly used AEDs in Rett syndrome, a genetic disorder associated with intellectual and physical disability. Study design - Cases (n=233) were sourced from the population-based Australian Rett Syndrome Database and longitudinal data were used. The Cox proportional hazard model was used to analyse relationships between fracture and prescribed AEDs, mobility, epilepsy diagnosis and genotype. Results - After controlling for mobility, epilepsy diagnosis and genotype, use of valproate increased the risk of fracture threefold after at least 1 year (HR 3.56; 95% CI 1.85 to 6.82) and after 2 or more years (HR 3.02; 95% CI 1.90 to 4.80). There was a lesser increased risk (HR 1.99; 95% CI 0.99 to 4.02) with lamotrigine in the first year of use but not for subsequent years of use. Carbamazepine slightly decreased the risk (HR 0.60; 95% CI 0.35 to 1.02) after 2 or more years of use. Conclusions - The effect of valproate on bone health should be considered when managing epilepsy in Rett syndrome. Multiple mechanisms could be contributing to this effect.
First published as cited above © BMJ Publishing Group Ltd
Showing items related by title, author, creator and subject.
Horne, T.; Leonard, H.; Stannage, K.; Downs, Jennepher (2017)Background: Children with severe disability often develop osteoporosis and have an increased risk of fracture. In Rett syndrome, the prevalence of fracture is four times greater than in the general population, and the ...
Fehr, S.; Bebbington, A.; Nassar, N.; Downs, Jennepher; Ronen, G.; de Klerk, N.; Leonard, H. (2011)Modifications to diagnostic criteria and introduction of genetic testing have likely affected the pattern and timing of Rett syndrome diagnosis. The trends in incidence and prevalence of Rett syndrome in Australia were ...
Clinical guidelines for management of bone health in Rett syndrome based on expert consensus and available evidenceJefferson, A.; Leonard, H.; Siafarikas, A.; Woodhead, H.; Fyfe, S.; Ward, L.; Munns, C.; Motil, K.; Tarquinio, D.; Shapiro, J.; Brismar, T.; Ben-Zeev, B.; Bisgaard, A.; Coppola, G.; Ellaway, C.; Freilinger, M.; Geerts, S.; Humphreys, P.; Jones, M.; Lane, J.; Larsson, G.; Lotan, M.; Percy, A.; Pineda, M.; Skinner, S.; Syhler, B.; Thompson, S.; Weiss, B.; Engerström, I.; Downs, Jennepher (2016)Objectives - We developed clinical guidelines for the management of bone health in Rett syndrome through evidence review and the consensus of an expert panel of clinicians. Methods - An initial guidelines draft was created ...